PharmaTher Announces Positive Research Results for PharmaPatch™ with N,N-dimethyltryptamine (DMT) and Strategic Investment into Sairiyo Therapeutics TORONTO, July 18, 2023 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a commercial-focused specialty pharmaceutical company, is pleased to...

DISQO and Research Results Forge New Managed Services Partnership Clients to Benefit from Custom Research Support And Highest Quality, First-Party Consumer Data and Insights LOS ANGELES and FITCHBURG, Mass., March 02, 2021 (GLOBE NEWSWIRE) -- Consumer insights...